The estimated Net Worth of Michael A. Gaul is at least 34.1 千$ dollars as of 16 November 2023. Mr Gaul owns over 10,000 units of Beyond Air stock worth over 34,105$ and over the last 9 years he sold XAIR stock worth over 0$.
Sign up
Mr Gaul XAIR stock SEC Form 4 insiders trading
Mr has made over 6 trades of the Beyond Air stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of XAIR stock worth 17,700$ on 16 November 2023.
The largest trade he's ever made was buying 10,000 units of Beyond Air stock on 16 November 2023 worth over 17,700$. On average, Mr trades about 2,377 units every 258 days since 2016. As of 16 November 2023 he still owns at least 88,150 units of Beyond Air stock.
You can see the complete history of Mr Gaul stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Michael A. Gaul biography
Michael A. Gaul is the Sr. VP of Operations at Beyond Air.
How old is Mr Gaul?
Mr Gaul is 65, he's been the Sr. VP of Operations of Beyond Air since . There are no older and 12 younger executives at Beyond Air.
What's Mr Gaul's mailing address?
Michael's mailing address filed with the SEC is C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530.
Insiders trading at Beyond Air
Over the last 5 years, insiders at Beyond Air have traded over 4,582,444$ worth of Beyond Air stock and bought 3,519,117 units worth 12,396,434$ . The most active insiders traders include Robert Carey、Steven A. Lisi、Amir Avniel. On average, Beyond Air executives and independent directors trade stock every 17 days with the average trade being worth of 15,492$. The most recent stock trade was executed by Steven A. Lisi on 15 August 2024, trading 50,000 units of XAIR stock currently worth 18,500$.
What does Beyond Air do?
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
What does Beyond Air's logo look like?
Complete history of Mr Gaul stock trades at Beyond Air
Beyond Air executives and stock owners
Beyond Air executives and other stock owners filed with the SEC include:
-
Steven Lisi,
Chairman of the Board, Chief Executive Officer -
Amir Avniel,
President, Chief Operating Officer, Director -
Adam Newman,
Chief Legal Officer and General Counsel -
Steven Adam Lisi,
CEO & Chairman -
Duncan Fatkin,
Chief Commercial Officer -
Douglas Beck,
Chief Financial Officer -
Amir Avniel,
Co-Founder, Pres, COO & Director -
Douglas J. Beck CPA, CPA,
Consultant -
William Forbes,
Independent Director -
Erick Lucera,
Independent Director -
Robert Carey,
Independent Director -
Yoori Lee,
Independent Director -
Ron Bentsur,
Independent Director -
Bob Yedid,
IR Contact Officer -
Prof. Andrew R. Colin M.D.,
Chief Medical Officer & Member of Scientific Advisory Board -
Kori-Ann Taylor,
Head of Marketing -
Rebecca Van Doren,
Head of Sales -
Maria Yonkoski,
Head of Investor Relations -
Douglas Quinton Larson,
CFO, Principal Financial Officer & Principal Accounting Officer -
Hila Confino Ph.D.,
Research Project Mang. -
Michael A. Gaul,
Sr. VP of Operations -
Ali Ardakani,
Sr. VP of Device & Bus. Devel. -
Dr. Giora Davidai M.D.,
Chief Medical Officer -
Douglas Quinton Larson,
Chief Financial Officer -
Michael A. Gaul,
Chief Operating Officer -
Jeff Lynn Myers,
Chief Medical Officer